Background Troponin elevation is common in hospitalized COVID-19 patients, but underlying aetiologies are ill-defined. We used multi-parametric cardiovascular magnetic resonance (CMR) to assess myocardial injury in recovered COVID-19 patients. Methods and results One hundred and forty-eight patients (64 ± 12 years, 70% male) with severe COVID-19 infection [all requiring hospital admission, 48 (32%) requiring ventilatory support] and troponin elevation discharged from six hospitals underwent convalescent CMR (including adenosine stress perfusion if indicated) at median 68 days.


Read more…

Citation: Tushar Kotecha, Daniel S Knight, Yousuf Razvi, Kartik Kumar, Kavitha Vimalesvaran, George Thornton, Rishi Patel, Liza Chacko, James T Brown, Clare Coyle, Donald Leith, Abhishek Shetye, Ben Ariff, Robert Bell, Gabriella Captur, Meg Coleman, James Goldring, Deepa Gopalan, Melissa Heightman, Toby Hillman, Luke Howard, Michael Jacobs, Paramjit S Jeetley, Prapa Kanagaratnam, Onn Min Kon, Lucy E Lamb, Charlotte H Manisty, Palmira Mathurdas, Jamil Mayet, Rupert Negus, Niket Patel, Iain Pierce, Georgina Russell, Anthony Wolff, Hui Xue, Peter Kellman, James C Moon, Thomas A Treibel, Graham D Cole, Marianna Fontana, Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance, European Heart Journal, 2021;, ehab075,